Zeke Capital Advisors, LLC Hepion Pharmaceuticals, Inc. Transaction History

Zeke Capital Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$1.39 - $2.1 $69,500 - $105,000	-50,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.58 - $3.64 $79,000 - $182,000	50,000 New	50,000 $110,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.